Showing results (111-120 of 194) with videos related to
Sort By:
Pageof 20
Kidney International Reports|October 11, 2022
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G TrialAndrew S Bomback, David Kavanagh, Marina Vivarelli, et al.Kidney International Reports|February 5, 2024
Iptacopan in Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 StudyMarina Vivarelli, Andrew S Bomback, Matthias Meier, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
A new map of glycosaminoglycan and C3b binding sites on factor HChristoph Q Schmidt, Andrew P Herbert, David Kavanagh, et al.Kidney International Reports|June 25, 2021
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in AdultsThomas Barbour, Marie Scully, Gema Ariceta, et al.Human Molecular Genetics|March 20, 2015
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levelsDavid Kavanagh, Yi Yu, Elizabeth C Schramm, et al.Journal of Medical Internet Research|December 21, 2010
Online alcohol interventions: a systematic reviewAngela White, David Kavanagh, Helen Stallman, et al.Investigative Ophthalmology & Visual Science|June 10, 2020
Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular DegenerationThomas M Hallam, Kevin J Marchbank, Claire L Harris, et al.Plos One|April 25, 2013
Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32Lucy V Holmes, Lisa Strain, Scott J Staniforth, et al.Transplantation|July 25, 2024
Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue TherapyCaroline Duineveld, Emily K Glover, Romy N Bouwmeester, et al.BMC Nephrology|April 19, 2021
Effectiveness of Wellbeing Intervention for Chronic Kidney Disease (WICKD): results of a randomised controlled trialKylie M Dingwall, Michelle Sweet, Alan Cass, et al.Pageof 20